Arcutis Biotherapeutics (ARQT) Revenue & Revenue Breakdown
Arcutis Biotherapeutics Revenue Highlights
Latest Revenue (Y)
$196.54M
Latest Revenue (Q)
$71.36M
Main Segment (Y)
Other Revenue
Arcutis Biotherapeutics Revenue by Period
Arcutis Biotherapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $196.54M | 229.74% |
| 2023-12-31 | $59.61M | 1517.09% |
| 2022-12-31 | $3.69M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
Arcutis Biotherapeutics generated $196.54M in revenue during NA 2024, up 229.74% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Arcutis Biotherapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $71.36M | 59.45% |
| 2024-09-30 | $44.76M | 45.04% |
| 2024-06-30 | $30.86M | -37.75% |
| 2024-03-31 | $49.57M | 266.47% |
| 2023-12-31 | $13.53M | -64.51% |
| 2023-09-30 | $38.11M | 634.28% |
| 2023-06-30 | $5.19M | 86.62% |
| 2023-03-31 | $2.78M | -6.08% |
| 2022-12-31 | $2.96M | 308.41% |
| 2022-09-30 | $725.00K | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | - |
Arcutis Biotherapeutics generated $71.36M in revenue during Q4 2024, up 59.45% compared to the previous quarter, and up 187.25% compared to the same period a year ago.
Arcutis Biotherapeutics Revenue Breakdown
Arcutis Biotherapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 |
|---|---|---|
| Product | $29.19M | $3.69M |
| Other Revenue | $30.42M | - |
Arcutis Biotherapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Other Revenue (51.04%), and Product (48.96%).
Quarterly Revenue by Product
| Product/Service | Dec 23 | Sep 23 | Dec 22 | Sep 22 |
|---|---|---|---|---|
| Product | $21.08M | $8.11M | $2.96M | $725.00K |
| Other Revenue | $420.00K | $30.00M | - | - |
Arcutis Biotherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Product (98.05%), and Other Revenue (1.95%).
Arcutis Biotherapeutics Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Dec 22 | Sep 22 |
|---|---|---|
| Product | $2.96M | $725.00K |
Arcutis Biotherapeutics's latest quarterly revenue breakdown by geography, as of Dec 22: Product (100.00%).
Arcutis Biotherapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals | $709.95M | $212.53M |
| MIRM | Mirum Pharmaceuticals | $336.89M | $99.41M |
| CHRS | Coherus BioSciences | $266.96M | $7.60M |
| ARQT | Arcutis Biotherapeutics | $196.54M | $71.36M |
| DAWN | Day One Biopharmaceuticals | $131.16M | $29.21M |
| AMLX | Amylyx Pharmaceuticals | $87.37M | $-665.00K |
| GLUE | Monte Rosa Therapeutics | $75.62M | $60.65M |
| SPRO | Spero Therapeutics | $47.98M | $9.36M |
| BOLT | Bolt Biotherapeutics | $7.69M | $1.22M |
| XFOR | X4 Pharmaceuticals | $2.56M | $28.81M |
| DSGN | Design Therapeutics | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| ERAS | Erasca | - | - |